C O M M U N I C A T I O N S
denaturation of the protein, which increases the solvent accessibility
of the tryptophan residue.
These initial studies indicate that transition metal-catalyzed
reactions are indeed capable of modifying native protein functional
groups with very high selectivity.14 The reaction described herein
represents one of the first methods for selective tryptophan
bioconjugation and one of the first examples of a metallocarbene-
based reaction in aqueous solution. Current efforts are focused on
increasing the pH of the reaction to broaden the substrate scope.
In light of the relatively low abundance of tryptophan residues
on protein surfaces, this technique offers a selective bioconjugation
strategy that complements more commonly used cys- and lys-based
reactions. This possibility is currently being explored for the
functionalization of introduced tryptophans on expressed proteins.
Furthermore, as tryptophan residues often occur in binding sites
and can serve as mediators of electron transfer,15 this reaction
provides a new tool to alter or block their participation in these
pathways.
Acknowledgment. We gratefully acknowledge the University
of California, Berkeley, the Nanoscale Science, Engineering, and
Technology Program (NSET), and the Center for New Directions
in Organic Synthesis. CNDOS is supported by Bristol-Myers Squibb
as a Sponsoring Member and Novartis Pharma as a Supporting
Member. J.M.A. was supported by a Berkeley Fellowship for
Graduate Study. We gratefully acknowledge Waters Inc. for access
to a Q-TOF Micro mass spectrometer, and Jacob M. Hooker for
his analysis expertise.
Supporting Information Available: Full experimental procedures
and characterization data for all compounds. This material is available
Figure 1. Modification of myoglobin with metallocarbenes. (a) A 100 µM
solution of horse heart myoglobin was exposed to 3 and Rh2(OAc)4 for 7
h. The two tryptophan residues are shown in green. (b) Following removal
of the small molecules via gel filtration, the sample was analyzed by ESI-
MS. Both singly and doubly modified protein products were identified in
the mass reconstruction. (c) In the absence of Rh2(OAc)4, no products were
obtained under otherwise identical conditions. (d) After digestion with
trypsin, MS/MS analysis of the doubly modified peptide fragment confirmed
modification of only the tryptophan residues. All assigned species agree to
within 0.1% of the expected mass values.
References
(1) Hermanson, G. T. Bioconjugate Techniques, 1st ed.; Academic Press: San
Diego, 1996.
(2) For recent examples, see: (a) Muir, T. W.; Sondhi, D.; Cole, P. A. P.
Natl. Acad. Sci. U.S.A. 1998, 95, 6705-6710. (b) Cotton, G. J.; Muir, T.
W. Chem. Biol. 1999, 6, R247-R256. (c) Wang, Q.; Chan, T. R.; Hilgraf,
R.; Fokin, V. V.; Sharpless, K. B.; Finn, M. G. J. Am. Chem. Soc. 2003,
125, 3192-3193. (d) Speers, A. E.; Adam, G. C.; Cravatt, B. F. J. Am.
Chem. Soc. 2003, 125, 4686-4687. (e) Saxon, E.; Bertozzi, C. R. Science
2000, 287, 2007-2010. (f) Nilsson, B. L.; Kiessling, L. L.; Raines, R. T.
Org. Lett. 2000, 2, 1939-1941. (g) Hooker, J. M.; Kovacs, E. W.; Francis,
M. B. J. Am. Chem. Soc. 2004, 126, 3718-3719.
(3) For examples employed in the context of biomolecules, see: (a) Mortell,
K. H.; Gingras, M.; Kiessling, L. L. J. Am. Chem. Soc. 1994, 116, 12053-
12054. (b) Dibowski, H.; Schmidtchen, F. P. Angew. Chem., Int. Ed. 1998,
37, 476-478. (c) Bong, D. T.; Ghadiri, M. R. Org. Lett. 2001, 3, 2509-
2511.
(4) (a) Ye, T.; McKervey, M. A. Chem. ReV. 1994, 94, 1091-1160. (b) Doyle,
M. P. Chem. ReV. 1986, 86, 919-939.
Figure 2. Modification of subtilisin Carlsberg with rhodium carbenoids.
Conditions: 100 µM protein, 10 mM 3, 100 µM Rh2(OAc)4 and 75 mM
HONH2‚HCl (pH 1.5) in 80% water/20% ethylene glycol, rt, 7 h. Following
removal of the small molecules via gel filtration, the sample was analyzed
using MALDI-TOF MS. Only the singly modified protein was observed,
as would be expected by the single tryptophan residue (shown in green).
In the absence of Rh2(OAc)4, no reaction occurred under otherwise identical
conditions.
(5) (a) Davies, H. M. L.; Clark, T. J.; Church, L. A. Tetrahedron Lett. 1989,
30, 5057-5060. (b) Davies, H. M. L.; Bruzinski, P. R.; Lake, D. H.; Kong,
N.; Fall, M. J. J. Am. Chem. Soc. 1996, 118, 6897-6907.
(6) Similar reactivity has been observed in CH2Cl2: (a) Salim, M.; Capretta,
A. Tetrahedron 2000, 56, 8063-8069. (b) Gibe, R.; Kerr, M. A. J. Org.
Chem. 2002, 67, 6247-6249.
(7) Miller, D. J.; Moody, C. J. Tetrahedron 1995, 51, 10811-10843.
(8) Davies, H. M. L.; Hutcheson, D. K. Tetrahedron Lett. 1993, 34, 7243-
7246.
(9) Khmelnitsky, Y. L.; Mozhaev, V. V.; Belova, A. B.; Sergeeva, M. V.;
protein structure,13 subsequent reconstitution experiments confirmed
that the modified myoglobin was still competent to bind the heme
group.11
Attempts to modify subtilisin Carlsberg, a protein possessing a
single tryptophan residue, were unsuccessful under analogous
conditions. However, by lowering the pH of the reaction to 1.5,
clean conversion to a singly modified product was observed, Figure
2. Trypsin digest analysis again confirmed that the reaction occurred
only on the portion of the protein containing the tryptophan residue,
W113. The higher conversion at lower pH presumably results from
Martinek, K. Eur. J. Biochem. 1991, 198, 31-41.
(10) Horse heart myoglobin structure from Maurus, R.; Bogumil, R.; Nguyen,
N. T.; Mauk, A. G.; Brayer, G. Biochem. J. 1998, 332, 67-74.
(11) See Supporting Information for details and spectra.
(12) These species are commonly observed for tryptophan residues: Falick,
A. M.; Hines, W. M.; Medzihradszky, K. F.; Baldwin, M. A.; Gibson, B.
W. J. Am. Soc. Mass Spectrom. 1993, 4, 882-893.
(13) Yang, A. Y.; Honig, B. J. Mol. Biol. 1994, 237, 602-614.
(14) The ability of the reaction to modify cysteine and methionine residues is
currently being evaluated.
(15) For examples, see: Stubbe, J.; Nocera, D. G.; Yee, C. S.; Chang, M. C.
Y. Chem. ReV. 2003, 103, 2167-2201.
JA047272C
9
J. AM. CHEM. SOC. VOL. 126, NO. 33, 2004 10257